期刊文献+

慢性心力衰竭药物治疗若干进展 被引量:1

The Progress of Drug Therapy about Chronic Heart Failure
下载PDF
导出
摘要 导致心力衰竭发生发展的基本机制是心室重塑,当代治疗慢性心力衰竭的关键就是抑制神经内分泌系统过度激活,阻断心室重塑。近年来国内外相继公布了不少有关治疗慢性心力衰竭的循证医学研究结果和诊治指南,本文重点综述血管紧张素转换酶抑制剂、β受体阻滞剂、血管紧张素Ⅱ受体阻滞剂、醛固酮拮抗剂及正性肌力药物在治疗慢性心力衰竭方面的若干进展。 The ventricle remodeling is. the basic mechanism resulting in the development of heart failure,the current criticality about its therapy lies in the inhibition of the over activation of neumroendocrine system in order to prevent its ventricle remodeling. Many researches from evidence -based medicine and guidances about diagnosis and treatment related heart failure have been published one after another around exterior and interior in recent years. This article puts the emphasis on the progress of many drugs for the treatment of heart failure including angiotemdn converting enzyme inhibitor,β -receptor blocker,blocker of angiotensin;angiotensin Ⅱ receptor,aldosterone antagonists and positive inotropic.
出处 《医学综述》 2006年第16期1013-1015,共3页 Medical Recapitulate
关键词 充血性心力衰竭 血管紧张素转换酶抑制剂 Β受体阻滞剂 血管紧张素Ⅱ受体阻滞剂 地高辛 Congestive cardiac failure Angiotensin converting enzyme inhibitor β-Receptor blocker Blocker of angiotensin Angiotensin Ⅱ receptor Digoxin
  • 相关文献

参考文献15

  • 1Braunwald E,Bristow MR.Congestive heart failure:fifty years of propress[J].Circulation,2000,102[20 Suppl 4]:IV14-23. 被引量:1
  • 2Bristow MR.Beta-adrenergic receptor blocdacde in chronic heart failure[J].Circulation,2000,101(5):558-569. 被引量:1
  • 3Shakar SF,Abraham WT,Robertson AD,et al.Comibned oral postive inotropic and beta-blocker therapy for treatment of refractory class Ⅳheart failure[J].JACC,1998,31 (2):1336. 被引量:1
  • 4徐成斌.慢性心力衰竭治疗新理念[J].中国医刊,2003,38(11):2-4. 被引量:26
  • 5Philbin EF,Rocco TA,Lindenmuth NW,et al.Systolic versus diastolic heart faihare in community practice:clinical featyures,outcomes,and the use of angiotensin-convering enzyme inhinitors[J].Am J Med,2000,109(8):605-613. 被引量:1
  • 6Unger T.Neurohormonal modulation in cardiovascular disease[J].Am Heart J,2002,139(12):2-8. 被引量:1
  • 7Cohn JN,Tognoni G.Valsartan Heart Failure Trial Investigators.A randomized trial of theangiotensin-receptor blocker valsartan in chronic heart failure[J].N Engl J Med,2001,345(23):1667-1675. 被引量:1
  • 8Coletta AP,Cleland JG,Freemantle N,et al.Clinical trials update from the European Society of Cardiology:CHARM,BASEL,EUROPA and ESTEEM[J].Eur J Heart Fail,2003,5(6):697-704. 被引量:1
  • 9Haim M,Shotan A,Boyko V,et al.Effect of beta-blocker therapy in patients with cardiol oronary disease in New York heart association classes Ⅱ and Ⅲ[J].Am J Cardiol,1998,81(9):1455. 被引量:1
  • 10Poole-Wilson PA,Swedlberg K,Cleland JG,et al.Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol European trial (COMET):randomized controlled trial[J].Lancet,2003,362(9377):7-13. 被引量:1

共引文献25

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部